Abstract
A host of bacteria and viruses are dependent on O-linked and N-linked glycosylation to perform vital biological functions. Pathogens often have integral proteins that participate in host-cell interactions such as receptor binding and fusion with host membrane. Fusion proteins from a broad range of disparate viruses, such as paramyxovirus, HIV, ebola, and the influenza viruses share a variety of common features that are augmented by glycosylation. Each of these viruses contain multiple glycosylation sites that must be processed and modified by the host post-translational machinery to be fusogenically active. In most viruses, glycosylation plays a role in biogenesis, stability, antigenicity and infectivity. In bacteria, glycosylation events play an important role in the formation of flagellin and pili and are vitally important to adherence, attachment, infectivity and immune evasion. With the importance of glycosylation to pathogen survival, it is clear that a better understanding of the processes is needed to understand the pathogen requirement for glycosylation and to capitalize on this requirement for the development of novel therapeutics.
[1] Witze E.S., Old W.M., Resing K.A., Ahn N.G., Mapping protein post-translational modifications with mass spectrometry, Nat. Methods, 2007, 4, 798–806 http://dx.doi.org/10.1038/nmeth110010.1038/nmeth1100Search in Google Scholar
[2] Spiro R.G., Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds, Glycobiology, 2002, 12, 43R–56R http://dx.doi.org/10.1093/glycob/12.4.43R10.1093/glycob/12.4.43RSearch in Google Scholar
[3] Stepper J., Shastri S., Loo T.S., Preston J.C., Novak P., Man P., et al., Cysteine S-glycosylation, a new post-translational modification found in glycopeptide bacteriocins, FEBS letters, 585, 645–650 10.1016/j.febslet.2011.01.023Search in Google Scholar
[4] Furmanek A., Hofsteenge J., Protein C-mannosylation: facts and questions, Acta Biochim. Polon., 2000, 47, 781–789 10.18388/abp.2000_3996Search in Google Scholar
[5] Falzarano D., Krokhin O., Van Domselaar G., Wolf K., Seebach J., Schnittler H.J., et al., Ebola sGP—the first viral glycoprotein shown to be C-mannosylated, Virology, 2007, 368, 83–90 http://dx.doi.org/10.1016/j.virol.2007.06.01510.1016/j.virol.2007.06.015Search in Google Scholar
[6] Hartmann S., Hofsteenge J., Properdin, the positive regulator of complement, is highly C-mannosylated, J. Biol. Chem., 2000, 275, 28569–72854 http://dx.doi.org/10.1074/jbc.M00173220010.1074/jbc.M001732200Search in Google Scholar
[7] Ristl R., Steiner K., Zarschler K., Zayni S., Messner P., Schaffer C., The s-layer glycome-adding to the sugar coat of bacteria, Int. J. Microbiol., 2011, pi 127870 10.1155/2011/127870Search in Google Scholar
[8] Apweiler R., Hermjakob H., Sharon N., On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database, Biochim. Biophys. Acta, 1999, 1473, 4–8 10.1016/S0304-4165(99)00165-8Search in Google Scholar
[9] Messner P., Prokaryotic glycoproteins: unexplored but important, J. Bacteriol., 2004, 186, 2517–2519 http://dx.doi.org/10.1128/JB.186.9.2517-2519.200410.1128/JB.186.9.2517-2519.2004Search in Google Scholar PubMed PubMed Central
[10] Weerapana E., Imperiali B., Asparagine-linked protein glycosylation: from eukaryotic to prokaryotic systems, Glycobiology, 2006, 16, 91R–101R http://dx.doi.org/10.1093/glycob/cwj09910.1093/glycob/cwj099Search in Google Scholar PubMed
[11] Neuberger A., Carbohydrates in protein: The carbohydrate component of crystalline egg albumin, Biochem. J., 1938, 32, 1435–1451 10.1042/bj0321435Search in Google Scholar
[12] Sleytr, U. B. and Thorne, K. J. (1976) Chemical characterization of the regularly arranged surface layers of Clostridium thermosaccharolyticum and Clostridium thermohydrosulfuricum. J Bacteriol 126, 377–83. 10.1128/jb.126.1.377-383.1976Search in Google Scholar
[13] Sleytr U.B., Heterologous reattachment of regular arrays of glycoproteins on bacterial surfaces, Nature, 1975, 257, 400–402 http://dx.doi.org/10.1038/257400a010.1038/257400a0Search in Google Scholar
[14] Szymanski C.M., Logan S.M., Linton D., Wren B.W., Campylobacter—a tale of two protein glycosylation systems, Trends Microbiol., 2003, 11, 233–238 http://dx.doi.org/10.1016/S0966-842X(03)00079-910.1016/S0966-842X(03)00079-9Search in Google Scholar
[15] Wacker M., Linton D., Hitchen P.G., Nita-Lazar M., Haslam S.M., North S.J., et al., N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli, Science, 2002, 298, 1790–1793 http://dx.doi.org/10.1126/science.298.5599.179010.1126/science.298.5599.1790Search in Google Scholar PubMed
[16] Abu-Qarn M., Eichler J., Protein N-glycosylation in Archaea: defining Haloferax volcanii genes involved in S-layer glycoprotein glycosylation, Mol. Microbiol., 2006, 61, 511–525 http://dx.doi.org/10.1111/j.1365-2958.2006.05252.x10.1111/j.1365-2958.2006.05252.xSearch in Google Scholar PubMed
[17] Logan S.M., Flagellar glycosylation — a new component of the motility repertoire?, Microbiology, 2006, 152, 1249–1262 http://dx.doi.org/10.1099/mic.0.28735-010.1099/mic.0.28735-0Search in Google Scholar PubMed
[18] Castric P., pilO, a gene required for glycosylation of Pseudomonas aeruginosa 1244 pilin, Microbiology, 1995, 141, 1247–1254 http://dx.doi.org/10.1099/13500872-141-5-124710.1099/13500872-141-5-1247Search in Google Scholar PubMed
[19] Fletcher C.M., Coyne M.J., Villa O.F., Chatzidaki-Livanis M., Comstock L.E. A general O-glycosylation system important to the physiology of a major human intestinal symbiont, Cell, 2009, 137, 321–331 http://dx.doi.org/10.1016/j.cell.2009.02.04110.1016/j.cell.2009.02.041Search in Google Scholar PubMed PubMed Central
[20] Coyne M.J., Reinap B., Lee M.M., Comstock L.E., Human symbionts use a host-like pathway for surface fucosylation, Science, 2005, 307, 1778–1781 http://dx.doi.org/10.1126/science.110646910.1126/science.1106469Search in Google Scholar PubMed
[21] Power P.M., Seib K.L., Jennings M.P., Pilin glycosylation in Neisseria meningitidis occurs by a similar pathway to wzy-dependent O-antigen biosynthesis in Escherichia coli, Biochem. Biophys. Res. Commun., 2006, 347, 904–908 http://dx.doi.org/10.1016/j.bbrc.2006.06.18210.1016/j.bbrc.2006.06.182Search in Google Scholar
[22] Stimson E., Virji M., Makepeace K., Dell A., Morris H., Payne G., et al., Meningococcal pilin: a glycoprotein substituted with digalactosyl 2,4-diacetamido-2,4,6-trideoxyhexose, Mol. Microbiol., 1995, 17, 1201–1214 http://dx.doi.org/10.1111/j.1365-2958.1995.mmi_17061201.x10.1111/j.1365-2958.1995.mmi_17061201.xSearch in Google Scholar
[23] Virji M., Post-translational modifications of meningococcal pili. Identification of common substituents: glycans and alpha-glycerophosphate—a review, Gene, 1997, 192, 141–147 http://dx.doi.org/10.1016/S0378-1119(97)00082-610.1016/S0378-1119(97)00082-6Search in Google Scholar
[24] Hegge F.T., Hitchen P.G., Aas F.E., Kristiansen H., Lovold C., Egge-Jacobsen W., Unique modifications with phosphocholine and phosphoethanolamine define alternate antigenic forms of Neisseria gonorrhoeae type IV pili, Proc. Natl. Acad. Sci. USA, 2004, 101, 10798–107803 http://dx.doi.org/10.1073/pnas.040239710110.1073/pnas.0402397101Search in Google Scholar PubMed PubMed Central
[25] Castric P., Cassels F.J., Carlson R.W., Structural characterization of the Pseudomonas aeruginosa 1244 pilin glycan, J. Biol. Chem., 2001, 276, 26479–26485 http://dx.doi.org/10.1074/jbc.M10268520010.1074/jbc.M102685200Search in Google Scholar PubMed
[26] Schirm M., Soo E.C., Aubry A.J., Austin J., Thibault P., Logan S.M., Structural, genetic and functional characterization of the flagellin glycosylation process in Helicobacter pylori, Mol. Microbiol., 2003, 48, 1579–1592 http://dx.doi.org/10.1046/j.1365-2958.2003.03527.x10.1046/j.1365-2958.2003.03527.xSearch in Google Scholar PubMed
[27] McNally D.J., Aubry A.J., Hui J.P., Khieu N.H., Whitfield D., Ewing C.P., et al., Targeted metabolomics analysis of Campylobacter coli VC167 reveals legionaminic acid derivatives as novel flagellar glycans, J. Biol. Chem., 2007, 282, 14463–14475 http://dx.doi.org/10.1074/jbc.M61102720010.1074/jbc.M611027200Search in Google Scholar PubMed
[28] Thibault P., Logan S.M., Kelly J.F., Brisson J.R., Ewing C.P., Trust T.J., et al., Identification of the carbohydrate moieties and glycosylation motifs in Campylobacter jejuni flagellin, J. Biol. Chem., 2001, 276, 34862–34870 http://dx.doi.org/10.1074/jbc.M10452920010.1074/jbc.M104529200Search in Google Scholar PubMed
[29] Sambri V., Stefanelli C., Cevenini R., Detection of glycoproteins in Borrelia burgdorferi, Arch. Microbiol., 1992, 157, 205–208 http://dx.doi.org/10.1007/BF0024515010.1007/BF00245150Search in Google Scholar PubMed
[30] Swanson A.F., Kuo C.C., Binding of the glycan of the major outer membrane protein of Chlamydia trachomatis to HeLa cells, Infect. Immun., 1994, 62, 24–28 10.1128/iai.62.1.24-28.1994Search in Google Scholar PubMed PubMed Central
[31] Swanson A.F., Kuo C.C., The characterization of lectin-binding proteins of Chlamydia trachomatis as glycoproteins, Microb. Pathog., 1991, 10, 465–473 http://dx.doi.org/10.1016/0882-4010(91)90112-N10.1016/0882-4010(91)90112-NSearch in Google Scholar
[32] Swanson A.F., Kuo C.C., Evidence that the major outer membrane protein of Chlamydia trachomatis is glycosylated, Infect. Immun., 1991, 59, 2120–2125 10.1128/iai.59.6.2120-2125.1991Search in Google Scholar
[33] Lindenthal C., Elsinghorst E.A., Enterotoxigenic Escherichia coli TibA glycoprotein adheres to human intestine epithelial cells, Infect. Immun., 2001, 69, 52–57 http://dx.doi.org/10.1128/IAI.69.1.52-57.200110.1128/IAI.69.1.52-57.2001Search in Google Scholar
[34] Lindenthal C., Elsinghorst E.A., Identification of a glycoprotein produced by enterotoxigenic Escherichia coli, Infect. Immun., 1999, 67, 4084–4091 10.1128/IAI.67.8.4084-4091.1999Search in Google Scholar
[35] Espitia C., Mancilla R., Identification, isolation and partial characterization of Mycobacterium tuberculosis glycoprotein antigens, Clin. Exp. Immunol., 1989, 77, 378–383 Search in Google Scholar
[36] Mondotte J.A., Lozach P.Y., Amara A., Gamarnik A.V., Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation, J. Virol., 2007, 81, 7136–7148 http://dx.doi.org/10.1128/JVI.00116-0710.1128/JVI.00116-07Search in Google Scholar
[37] Korber B., Gaschen B., Yusim K., Thakallapally R., Kesmir C., Detours V., Evolutionary and immunological implications of contemporary HIV-1 variation, Br. Med. Bull., 2001, 58, 19–42 http://dx.doi.org/10.1093/bmb/58.1.1910.1093/bmb/58.1.19Search in Google Scholar
[38] Wei X., Decker J.M., Wang S., Hui H., Kappes J.C., Wu X., et al., Antibody neutralization and escape by HIV-1, Nature, 2003, 422, 307–312 http://dx.doi.org/10.1038/nature0147010.1038/nature01470Search in Google Scholar
[39] Land A., Braakman I., Folding of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum, Biochimie, 2001, 83, 783–790 http://dx.doi.org/10.1016/S0300-9084(01)01314-110.1016/S0300-9084(01)01314-1Search in Google Scholar
[40] Slater-Handshy T., Droll D.A., Fan X., Di Bisceglie A.M., Chambers T.J., HCV E2 glycoprotein: mutagenesis of N-linked glycosylation sites and its effects on E2 expression and processing, Virology, 2004, 319, 36–48 http://dx.doi.org/10.1016/j.virol.2003.10.00810.1016/j.virol.2003.10.008Search in Google Scholar PubMed
[41] Meunier J.C., Fournillier A., Choukhi A., Cahour A., Cocquerel L., Dubuisson J., et al., Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of E1 glycans on the formation of the HCV glycoprotein complex, J. Gen. Virol., 1999, 80, 887–896 10.1099/0022-1317-80-4-887Search in Google Scholar PubMed
[42] Wagner R., Wolff T., Herwig A., Pleschka S., Klenk H.D., Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics, J. Virol., 2000, 74, 6316–6323 http://dx.doi.org/10.1128/JVI.74.14.6316-6323.200010.1128/JVI.74.14.6316-6323.2000Search in Google Scholar
[43] Klenk H.D., Wagner R., Heuer D., Wolff T., Importance of hemagglutinin glycosylation for the biological functions of influenza virus, Virus Res., 2002, 82, 73–75 http://dx.doi.org/10.1016/S0168-1702(01)00389-610.1016/S0168-1702(01)00389-6Search in Google Scholar
[44] Baigent S.J., McCauley J.W., Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture, Virus Res., 2001, 79, 177–185 http://dx.doi.org/10.1016/S0168-1702(01)00272-610.1016/S0168-1702(01)00272-6Search in Google Scholar
[45] Tsuchiya E., Sugawara K., Hongo S., Matsuzaki Y., Muraki Y., Nakamura K., Role of overlapping glycosylation sequons in antigenic properties, intracellular transport and biological activities of influenza A/H2N2 virus haemagglutinin, J. Gen. Virol., 2002, 83, 3067–3074 10.1099/0022-1317-83-12-3067Search in Google Scholar
[46] Tsuchiya E., Sugawara K., Hongo S., Matsuzaki Y., Muraki Y., Li Z.N., et al., Effect of addition of new oligosaccharide chains to the globular head of influenza A/H2N2 virus haemagglutinin on the intracellular transport and biological activities of the molecule, J. Gen. Virol., 2002, 83, 1137–1146 10.1099/0022-1317-83-5-1137Search in Google Scholar
[47] Abe Y., Takashita E., Sugawara K., Matsuzaki Y., Muraki Y., Hongo S., Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin, J. Virol., 2004, 78, 9605–9611 http://dx.doi.org/10.1128/JVI.78.18.9605-9611.200410.1128/JVI.78.18.9605-9611.2004Search in Google Scholar
[48] Kaverin N.V., Rudneva I.A., Ilyushina N.A., Varich N.L., Lipatov A.S., Smirnov Y.A., et al., Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants, J. Gen. Virol., 2002, 83, 2497–2505 10.1099/0022-1317-83-10-2497Search in Google Scholar
[49] Londrigan S.L., Turville S.G., Tate M.D., Deng Y.M., Brooks A.G., Reading P.C., N-linked Glycosylation Facilitates Sialic Acid-Independent Attachment and Entry of Influenza A Viruses into Cells Expressing DC-SIGN or L-SIGN, J. Virol., 2010, 85, 2990–3000 http://dx.doi.org/10.1128/JVI.01705-1010.1128/JVI.01705-10Search in Google Scholar
[50] Daniels R., Kurowski B., Johnson A.E., Hebert D.N., N-linked glycans direct the cotranslational folding pathway of influenza hemagglutinin, Mol. Cell, 2003, 11, 79–90 http://dx.doi.org/10.1016/S1097-2765(02)00821-310.1016/S1097-2765(02)00821-3Search in Google Scholar
[51] Skehel J.J., Wiley D.C., Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin, Ann. Rev. Biochem., 2000, 69, 531–569 http://dx.doi.org/10.1146/annurev.biochem.69.1.53110.1146/annurev.biochem.69.1.531Search in Google Scholar PubMed
[52] Vigerust D.J., Ulett K.B., Boyd K.L., Madsen J., Hawgood S., McCullers J.A., N-linked glycosylation attenuates H3N2 influenza viruses, J. Virol., 2007, 81, 8593–8600 http://dx.doi.org/10.1128/JVI.00769-0710.1128/JVI.00769-07Search in Google Scholar PubMed PubMed Central
[53] Job E.R., Deng Y.M., Tate M.D., Bottazzi B., Crouch E.C., Dean M.M., et al., Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies, J. Immunol., 2010, 185, 4284–4291 http://dx.doi.org/10.4049/jimmunol.100161310.4049/jimmunol.1001613Search in Google Scholar PubMed
[54] Deshpande K.L., Fried V.A., Ando M., Webster R.G., Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence, Proc. Natl. Acad. Sci. USA, 1987, 84, 36–40 http://dx.doi.org/10.1073/pnas.84.1.3610.1073/pnas.84.1.36Search in Google Scholar PubMed PubMed Central
[55] Zambon M.C., Epidemiology and pathogenesis of influenza, J. Antimicrob. Chemother., 1999, 44, 3–9 http://dx.doi.org/10.1093/jac/44.suppl_2.310.1093/jac/44.suppl_2.3Search in Google Scholar PubMed
[56] Das S.R., Puigbo P., Hensley S.E., Hurt D.E., Bennink J.R., Yewdell J.W., Glycosylation focuses sequence variation in the influenza A virus H1 hemagglutinin globular domain, PLoS Pathog., 2010, 6, e1001211 http://dx.doi.org/10.1371/journal.ppat.100121110.1371/journal.ppat.1001211Search in Google Scholar PubMed PubMed Central
[57] Martin-Gallardo A., Fleischer E., Doyle S.A., Arumugham R., Collins P.L., Hildreth S.W., et al., Expression of the G glycoprotein gene of human respiratory syncytial virus in Salmonella typhimurium, J. Gen. Virol., 1993, 74, 453–458 http://dx.doi.org/10.1099/0022-1317-74-3-45310.1099/0022-1317-74-3-453Search in Google Scholar PubMed
[58] Collins P.L., Mottet G., Oligomerization and posttranslational processing of glycoprotein G of human respiratory syncytial virus: altered O-glycosylation in the presence of brefeldin A, J. Gen. Virol., 1992, 73, 849–863 http://dx.doi.org/10.1099/0022-1317-73-4-84910.1099/0022-1317-73-4-849Search in Google Scholar PubMed
[59] Aguilar H.C., Matreyek K.A., Filone C.M., Hashimi S.T., Levroney E.L., Negrete O.A., et al., N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry, J. Virol., 2006, 80, 4878–4889 http://dx.doi.org/10.1128/JVI.80.10.4878-4889.200610.1128/JVI.80.10.4878-4889.2006Search in Google Scholar PubMed PubMed Central
[60] Moll M., Kaufmann A., Maisner A., Influence of N-glycans on processing and biological activity of the nipah virus fusion protein, J. Virol., 2004, 78, 7274–7278 http://dx.doi.org/10.1128/JVI.78.13.7274-7278.200410.1128/JVI.78.13.7274-7278.2004Search in Google Scholar PubMed PubMed Central
[61] Bossart K.N., Crameri G., Dimitrov A.S., Mungall B.A., Feng Y.R., Patch J.R., et al., Receptor binding, fusion inhibition, and induction of crossreactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus, J. Virol., 2005, 79, 6690–6702 http://dx.doi.org/10.1128/JVI.79.11.6690-6702.200510.1128/JVI.79.11.6690-6702.2005Search in Google Scholar PubMed PubMed Central
[62] Oostra M., de Haan C.A., de Groot R.J., Rottier P.J., Glycosylation of the severe acute respiratory syndrome coronavirus triple-spanning membrane proteins 3a and M., J. Virol., 2006, 80, 2326–2336 http://dx.doi.org/10.1128/JVI.80.5.2326-2336.200610.1128/JVI.80.5.2326-2336.2006Search in Google Scholar PubMed PubMed Central
[63] Schowalter R.M., Smith S.E., Dutch R.E., Characterization of Human Metapneumovirus F Protein-Promoted Membrane Fusion: Critical Roles for Proteolytic Processing and Low pH, J. Virol., 2006, 80, 10931–10941 http://dx.doi.org/10.1128/JVI.01287-0610.1128/JVI.01287-06Search in Google Scholar PubMed PubMed Central
[64] Bowden T.A., Crispin M., Harvey D.J., Jones E.Y., Stuart D.I., Dimeric architecture of the Hendra virus attachment glycoprotein: evidence for a conserved mode of assembly, J. Virol., 2010, 84, 6208–6217 http://dx.doi.org/10.1128/JVI.00317-1010.1128/JVI.00317-10Search in Google Scholar PubMed PubMed Central
[65] Bowden T.A., Crispin M., Harvey D.J., Aricescu A.R., Grimes J.M., Jones E.Y., et al., Crystal structure and carbohydrate analysis of Nipah virus attachment glycoprotein: a template for antiviral and vaccine design, J. Virol., 2008, 82, 11628–11636 http://dx.doi.org/10.1128/JVI.01344-0810.1128/JVI.01344-08Search in Google Scholar PubMed PubMed Central
[66] Botarelli P., Houlden B.A., Haigwood N.L., Servis C., Montagna D., Abrignani S., N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytes, J. Immunol., 1991, 147, 3128–3132 Search in Google Scholar
[67] Zhu, X., Borchers, C., Bienstock, R. J., Tomer, K. B. (2000) Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells. Biochemistry 39, 11194–204. http://dx.doi.org/10.1021/bi000432m10.1021/bi000432mSearch in Google Scholar PubMed
[68] Doores K.J., Bonomelli C., Harvey D.J., Vasiljevic S., Dwek R.A., Burton D.R., et al., Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens, Proc. Natl. Acad. Sci. USA, 2010, 107, 13800–13805 http://dx.doi.org/10.1073/pnas.100649810710.1073/pnas.1006498107Search in Google Scholar PubMed PubMed Central
[69] Fenouillet E., Gluckman J.C., Bahraoui E., Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1, J. Virol., 1990, 64, 2841–2848 10.1128/jvi.64.6.2841-2848.1990Search in Google Scholar PubMed PubMed Central
[70] Montefiori D.C., Robinson W.E. Jr., Mitchell W.M., Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1, Proc. Natl. Acad. Sci. USA, 1988, 85, 9248–9252 http://dx.doi.org/10.1073/pnas.85.23.924810.1073/pnas.85.23.9248Search in Google Scholar PubMed PubMed Central
[71] Wyatt R., Kwong P.D., Desjardins E., Sweet R.W., Robinson J., Hendrickson W.A., et al., The antigenic structure of the HIV gp120 envelope glycoprotein, Nature, 1998, 393, 705–711 http://dx.doi.org/10.1038/3151410.1038/31514Search in Google Scholar PubMed
[72] Poumbourios P., Maerz A.L., Drummer H.E., Functional evolution of the HIV-1 envelope glycoprotein 120 association site of glycoprotein 41, J. Biol. Chem., 2003, 278, 42149–42160 http://dx.doi.org/10.1074/jbc.M30522320010.1074/jbc.M305223200Search in Google Scholar PubMed
[73] Bunnik E.M., Euler Z., Welkers M.R., Boeser-Nunnink B.D., Grijsen M.L., Prins J.M., et al., Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level, Nat. Med., 2010, 16, 995–997 http://dx.doi.org/10.1038/nm.220310.1038/nm.2203Search in Google Scholar PubMed
[74] Chaillon A., Braibant M., Moreau T., Thenin S., Moreau A., Autran B., et al., The V1V2 domain and a N-linked glycosylation site in the V3 loop of the HIV-1 envelope glycoprotein modulate neutralization sensitivity to the human broadly neutralizing antibody 2G12, J. Virol., 2011, 85, 3642–3648 http://dx.doi.org/10.1128/JVI.02424-1010.1128/JVI.02424-10Search in Google Scholar PubMed PubMed Central
[75] Sanders R.W., Venturi M., Schiffner L., Kalyanaraman R., Katinger H., Lloyd K.O., et al., The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120, J. Virol., 2002, 76, 7293–7305 http://dx.doi.org/10.1128/JVI.76.14.7293-7305.200210.1128/JVI.76.14.7293-7305.2002Search in Google Scholar
[76] Calarese D.A., Lee H.K., Huang C.Y., Best M.D., Astronomo R.D., Stanfield R.L., et al., Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12, Proc. Natl. Acad. Sci. USA, 2005, 102, 13372–13377 http://dx.doi.org/10.1073/pnas.050576310210.1073/pnas.0505763102Search in Google Scholar PubMed PubMed Central
[77] Calarese D.A., Scanlan C.N., Zwick M.B., Deechongkit S., Mimura Y., Kunert R., et al., Antibody domain exchange is an immunological solution to carbohydrate cluster recognition, Science, 2003, 300, 2065–2071 http://dx.doi.org/10.1126/science.108318210.1126/science.1083182Search in Google Scholar PubMed
[78] Lai J., Bernhard O.K., Turville S.G., Harman A.N., Wilkinson J., Cunningham A.L., Oligomerization of the macrophage mannose receptor enhances gp120-mediated binding of HIV-1, J. Biol. Chem., 2009, 284, 11027–110238 http://dx.doi.org/10.1074/jbc.M80969820010.1074/jbc.M809698200Search in Google Scholar PubMed PubMed Central
[79] Frost S.D., Wrin T., Smith D.M., Kosakovsky Pond S.L., Liu Y., Paxinos E., et al., Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 enveloped Search in Google Scholar
[80] Bonhomme C.J., Capul A.A., Lauron E.J., Bederka L.H., Knopp K.A., Buchmeier M.J. Glycosylation modulates arenavirus glycoprotein expression and function, Virology, 2011, 409, 223–233 http://dx.doi.org/10.1016/j.virol.2010.10.01110.1016/j.virol.2010.10.011Search in Google Scholar PubMed PubMed Central
[81] Feldmann H., Nichol S.T., Klenk H.D., Peters C.J., Sanchez A., Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein, Virology, 1994, 199, 469–473 http://dx.doi.org/10.1006/viro.1994.114710.1006/viro.1994.1147Search in Google Scholar PubMed
[82] Simmons G., Wool-Lewis R.J., Baribaud F., Netter R.C., Bates P., Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence, J. Virol., 2002, 76, 2518–2528 http://dx.doi.org/10.1128/jvi.76.5.2518-2528.200210.1128/jvi.76.5.2518-2528.2002Search in Google Scholar PubMed PubMed Central
[83] Dowling W., Thompson E., Badger C., Mellquist J.L., Garrison A.R., Smith J.M., et al., Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines, J. Virol., 2007, 81, 1821–1837 http://dx.doi.org/10.1128/JVI.02098-0610.1128/JVI.02098-06Search in Google Scholar PubMed PubMed Central
[84] Shi X., Elliott R.M., Analysis of N-linked glycosylation of hantaan virus glycoproteins and the role of oligosaccharide side chains in protein folding and intracellular trafficking, J. Virol., 2004, 78, 5414–5422 http://dx.doi.org/10.1128/JVI.78.10.5414-5422.200410.1128/JVI.78.10.5414-5422.2004Search in Google Scholar
[85] Zheng F., Ma L., Shao L., Wang G., Chen F., Zhang Y., et al., Defining the N-linked glycosylation site of Hantaan virus envelope glycoproteins essential for cell fusion, J. Microbiol., 2007, 45, 41–47 Search in Google Scholar
[86] Robinson M.J., Sancho D., Slack E.C., LeibundGut-Landmann S., Reis e Sousa C., Myeloid C-type lectins in innate immunity, Nat. Immunol., 2006, 7, 1258–1265 http://dx.doi.org/10.1038/ni141710.1038/ni1417Search in Google Scholar PubMed
[87] Weis W.I., Taylor M.E., Drickamer K., The C-type lectin superfamily in the immune system, Immunol. Rev., 1998, 163, 19–34 http://dx.doi.org/10.1111/j.1600-065X.1998.tb01185.x10.1111/j.1600-065X.1998.tb01185.xSearch in Google Scholar
[88] Cambi A., de Lange F., van Maarseveen N.M., Nijhuis M., Joosten B., van Dijk E.M., et al., Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells, J. Cell Biol., 2004, 64, 145–155 http://dx.doi.org/10.1083/jcb.20030611210.1083/jcb.200306112Search in Google Scholar PubMed PubMed Central
[89] Cambi A., Figdor C.G., Dual function of C-type lectin-like receptors in the immune system, Curr. Opin. Cell Biol., 2003, 15, 539–546 http://dx.doi.org/10.1016/j.ceb.2003.08.00410.1016/j.ceb.2003.08.004Search in Google Scholar PubMed
[90] Geijtenbeek T.B., van Vliet S.J., Engering A., Hart B.A., van Kooyk Y., Self- and nonself-recognition by C-type lectins on dendritic cells, Annu. Rev. Immunol., 2004, 22, 33–54 http://dx.doi.org/10.1146/annurev.immunol.22.012703.10455810.1146/annurev.immunol.22.012703.104558Search in Google Scholar PubMed
[91] Rogers N.C., Slack E.C., Edwards A.D., Nolte M.A., Schulz O., Schweighoffer E., et al., Sykdependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins, Immunity, 2005, 22, 507–517 http://dx.doi.org/10.1016/j.immuni.2005.03.00410.1016/j.immuni.2005.03.004Search in Google Scholar PubMed
[92] Meyer-Wentrup F., Cambi A., Adema G.J., Figdor C.G., “Sweet talk”: closing in on C type lectin signaling, Immunity, 2005, 22, 399–400 http://dx.doi.org/10.1016/j.immuni.2005.04.00110.1016/j.immuni.2005.04.001Search in Google Scholar PubMed
[93] Upham J.P., Pickett D., Irimura T., Anders E.M., Reading P.C., Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry, J. Virol., 2010, 84, 3730–3737 http://dx.doi.org/10.1128/JVI.02148-0910.1128/JVI.02148-09Search in Google Scholar PubMed PubMed Central
[94] Reading P.C., Miller J.L., Anders E.M., Involvement of the mannose receptor in infection of macrophages by influenza virus, J. Virol., 2000, 74, 5190–5197 http://dx.doi.org/10.1128/JVI.74.11.5190-5197.200010.1128/JVI.74.11.5190-5197.2000Search in Google Scholar
[95] Nguyen D.G., Hildreth J.E., Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages, Eur. J. Immunol., 2003, 33, 483–493 http://dx.doi.org/10.1002/immu.20031002410.1002/immu.200310024Search in Google Scholar PubMed
[96] Vigerust D.J., Egan B.S., Shepherd V.L., HIV-1 Nef mediates post-translational down-regulation and redistribution of the mannose receptor, J. Leukoc. Biol., 2005, 77, 522–534 http://dx.doi.org/10.1189/jlb.080445410.1189/jlb.0804454Search in Google Scholar PubMed
[97] Reiling N., Blumenthal A., Flad H.D., Ernst M., Ehlers S., Mycobacteria-induced TNF-alpha and IL-10 formation by human macrophages is differentially regulated at the level of mitogenactivated protein kinase activity, J. Immunol., 2001, 167, 3339–3345 10.4049/jimmunol.167.6.3339Search in Google Scholar PubMed
[98] Bergman M., Del Prete G., van Kooyk Y., Appelmelk B., Helicobacter pylori phase variation, immune modulation and gastric autoimmunity, Nat. Rev. Microbiol., 2006, 4, 151–159 http://dx.doi.org/10.1038/nrmicro134410.1038/nrmicro1344Search in Google Scholar PubMed
[99] Cocquerel L., Voisset C., Dubuisson J., Hepatitis C virus entry: potential receptors and their biological functions, J. Gen. Virol., 2006, 87, 1075–1084 http://dx.doi.org/10.1099/vir.0.81646-010.1099/vir.0.81646-0Search in Google Scholar PubMed
[100] Lozach P.Y., Lortat-Jacob H., de Lacroix de Lavalette A., Staropoli I., Foung S., Amara, A., et al., DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2, J. Biol. Chem., 2003, 278, 20358–20366 http://dx.doi.org/10.1074/jbc.M30128420010.1074/jbc.M301284200Search in Google Scholar PubMed
[101] Martina B.E., Koraka P., van den Doel P., Rimmelzwaan G.F., Haagmans B.L., Osterhaus A.D., DC-SIGN enhances infection of cells with glycosylated West Nile virus in vitro and virus replication in human dendritic cells induces production of IFN-alpha and TNF-alpha, Virus Res., 2008, 135, 64–71 http://dx.doi.org/10.1016/j.virusres.2008.02.00810.1016/j.virusres.2008.02.008Search in Google Scholar PubMed
[102] Hacker K., White L., de Silva A.M., N-linked glycans on dengue viruses grown in mammalian and insect cells, J. Gen. Virol., 2009, 90, 2097–2106 http://dx.doi.org/10.1099/vir.0.012120-010.1099/vir.0.012120-0Search in Google Scholar PubMed PubMed Central
[103] Davis C.W., Mattei L.M., Nguyen H.Y., Ansarah-Sobrinho C., Doms R.W., Pierson T.C., The location of asparagine-linked glycans on West Nile virions controls their interactions with CD209 (DCSIGN), J. Biol. Chem., 2006, 281, 37183–37194 http://dx.doi.org/10.1074/jbc.M60542920010.1074/jbc.M605429200Search in Google Scholar PubMed
[104] Davis C.W., Nguyen H.Y., Hanna S.L., Sanchez M.D., Doms R.W., Pierson T.C., West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection, J. Virol., 2006, 80, 1290–1301 http://dx.doi.org/10.1128/JVI.80.3.1290-1301.200610.1128/JVI.80.3.1290-1301.2006Search in Google Scholar PubMed PubMed Central
[105] Lin G., Simmons G., Pohlmann S., Baribaud F., Ni H., Leslie G.J., et al., Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR, J. Virol., 2003, 77, 1337–1346 http://dx.doi.org/10.1128/JVI.77.2.1337-1346.200310.1128/JVI.77.2.1337-1346.2003Search in Google Scholar
[106] Turville S.G., Arthos J., Donald K.M., Lynch G., Naif H., Clark G., et al., HIV gp120 receptors on human dendritic cells, Blood, 2001, 98, 2482–2488 http://dx.doi.org/10.1182/blood.V98.8.248210.1182/blood.V98.8.2482Search in Google Scholar
[107] Liu Y., Liu H., Kim B.O., Gattone V.H., Li J., Nath A., et al., CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor, J. Virol., 2004, 78, 4120–4133 http://dx.doi.org/10.1128/JVI.78.8.4120-4133.200410.1128/JVI.78.8.4120-4133.2004Search in Google Scholar PubMed PubMed Central
[108] Gramberg T., Hofmann H., Moller P., Lalor P.F., Marzi A., Geier M., et al., LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus, Virology, 2005, 340, 224–236 http://dx.doi.org/10.1016/j.virol.2005.06.02610.1016/j.virol.2005.06.026Search in Google Scholar PubMed PubMed Central
[109] Pipirou Z., Powlesland A.S., Steffen I., Pohlmann S., Taylor M.E., Drickamer K., Mouse LSECtin as a model for a human Ebola virus receptor, Glycobiology, 2011, 21, 806–812 http://dx.doi.org/10.1093/glycob/cwr00810.1093/glycob/cwr008Search in Google Scholar PubMed PubMed Central
[110] Li Y., Hao B., Kuai X., Xing G., Yang J., Chen J., et al., C-type lectin LSECtin interacts with DCSIGNR and is involved in hepatitis C virus binding, Mol. Cell. Biochem., 2009, 327, 183–190 http://dx.doi.org/10.1007/s11010-009-0056-y10.1007/s11010-009-0056-ySearch in Google Scholar PubMed PubMed Central
[111] Francois K.O., Balzarini J., Potential of carbohydrate-binding agents as therapeutics against enveloped viruses, Med. Res. Rev., 2010, 31 10.1002/med.20216Search in Google Scholar PubMed PubMed Central
[112] Witvrouw M., Fikkert V., Hantson A., Pannecouque C., O’Keefe B.R., McMahon J., et al., Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A, J. Virol., 2005, 79, 7777–7784 http://dx.doi.org/10.1128/JVI.79.12.7777-7784.200510.1128/JVI.79.12.7777-7784.2005Search in Google Scholar PubMed PubMed Central
[113] Williams D.C. Jr., Lee J.Y., Cai M., Bewley C.A., Clore G.M., Crystal structures of the HIV-1 inhibitory cyanobacterial protein MVL free and bound to Man3GlcNAc2: structural basis for specificity and high-affinity binding to the core pentasaccharide from n-linked oligomannoside, J. Biol. Chem., 2005, 280, 29269–29276 http://dx.doi.org/10.1074/jbc.M50464220010.1074/jbc.M504642200Search in Google Scholar PubMed
[114] Balzarini J., Van Herrewege Y., Vermeire K., Vanham G., Schols D., Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes, Mol. Pharmacol., 2007, 71, 3–11 http://dx.doi.org/10.1124/mol.106.03015510.1124/mol.106.030155Search in Google Scholar PubMed
[115] O’Keefe B.R., Smee D.F., Turpin J.A., Saucedo C.J., Gustafson K.R., Mori T., et al., Potent antiinfluenza activity of cyanovirin-N and interactions with viral hemagglutinin, Antimicrob. Agents Chemother., 2003, 47, 2518–2525 http://dx.doi.org/10.1128/AAC.47.8.2518-2525.200310.1128/AAC.47.8.2518-2525.2003Search in Google Scholar
[116] Balzarini J., Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses?, Antivir. Chem. Chemother., 2007, 18, 1–11 10.1177/095632020701800101Search in Google Scholar
[117] Bertaux C., Daelemans D., Meertens L., Cormier E.G., Reinus J.F., Peumans W.J., et al., Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions, Virology, 2007, 36, 40–50 http://dx.doi.org/10.1016/j.virol.2007.04.00810.1016/j.virol.2007.04.008Search in Google Scholar
[118] Micewicz E.D., Cole A.L., Jung C.L., Luong H., Phillips M.L., Pratikhya P., et al., Grifonin-1: a small HIV-1 entry inhibitor derived from the algal lectin, Griffithsin, PLoS One, 2010, 5, e14360 http://dx.doi.org/10.1371/journal.pone.001436010.1371/journal.pone.0014360Search in Google Scholar
[119] Romanelli F., Smith K.M., Hoven A.D., Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity, Curr. Pharm. Des., 2004, 10, 2643–2648 http://dx.doi.org/10.2174/138161204338379110.2174/1381612043383791Search in Google Scholar
[120] Boelaert J.R., Sperber K., Piette J., Chloroquine exerts an additive in vitro anti-HIV type 1 effect when associated with didanosine and hydroxyurea, AIDS Res. Hum. Retroviruses, 1999, 15, 1241–7124 http://dx.doi.org/10.1089/08892229931013310.1089/088922299310133Search in Google Scholar
[121] Sperber K., Louie M., Kraus T., Proner J., Sapira E., Lin S., et al., Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1, Clin. Ther., 1995, 17, 622–636 http://dx.doi.org/10.1016/0149-2918(95)80039-510.1016/0149-2918(95)80039-5Search in Google Scholar
[122] Paton N.I., Aboulhab J., Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV-infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks, HIV Med., 2005, 6, 13–20 http://dx.doi.org/10.1111/j.1468-1293.2005.00259.x10.1111/j.1468-1293.2005.00259.xSearch in Google Scholar PubMed
[123] Naarding M.A., Baan E., Pollakis G., Paxton W.A., Effect of chloroquine on reducing HIV-1 replication in vitro and the DC-SIGN mediated transfer of virus to CD4+ T-lymphocytes, Retrovirology, 2007, 4, 6 http://dx.doi.org/10.1186/1742-4690-4-610.1186/1742-4690-4-6Search in Google Scholar PubMed PubMed Central
[124] Vincent M.J., Bergeron E., Benjannet S., Erickson B.R., Rollin P.E., Ksiazek T.G., et al., Chloroquine is a potent inhibitor of SARS coronavirus infection and spread, Virol. J., 2005, 2, 69 http://dx.doi.org/10.1186/1743-422X-2-6910.1186/1743-422X-2-69Search in Google Scholar PubMed PubMed Central
[125] De Clercq E., Potential antivirals and antiviral strategies against SARS coronavirus infections, Expert Rev. Anti Infect. Ther., 2006, 4, 291–302 http://dx.doi.org/10.1586/14787210.4.2.29110.1586/14787210.4.2.291Search in Google Scholar
[126] Keyaerts E., Vijgen L., Maes P., Neyts J., Van Ranst M., In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine, Biochem. Biophys. Res. Commun., 2004, 323, 264–268 http://dx.doi.org/10.1016/j.bbrc.2004.08.08510.1016/j.bbrc.2004.08.085Search in Google Scholar
[127] Di Trani L., Savarino A., Campitelli L., Norelli S., Puzelli S., D’Ostilio D., et al., Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses, Virol. J., 2007, 4, 39 http://dx.doi.org/10.1186/1743-422X-4-3910.1186/1743-422X-4-39Search in Google Scholar
[128] Ooi E.E., Chew J.S., Loh J.P., Chua R.C., In vitro inhibition of human influenza A virus replication by chloroquine, Virol. J., 2006, 3, 39 http://dx.doi.org/10.1186/1743-422X-3-3910.1186/1743-422X-3-39Search in Google Scholar
[129] Savarino A., Di Trani L., Donatelli I., Cauda R., Cassone A., New insights into the antiviral effects of chloroquine, Lancet Infect. Dis., 2006, 6, 67–69 http://dx.doi.org/10.1016/S1473-3099(06)70361-910.1016/S1473-3099(06)70361-9Search in Google Scholar
[130] Rolain J.M., Colson P., Raoult D., Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century, Int. J. Antimicrob. Agents, 2007, 30, 297–308 http://dx.doi.org/10.1016/j.ijantimicag.2007.05.01510.1016/j.ijantimicag.2007.05.015Search in Google Scholar
[131] Vigerust D.J., McCullers J.A., Chloroquine is effective against influenza A virus in vitro but not in vivo, Influenza Other Respi Viruses, 2007, 1, 189–192 http://dx.doi.org/10.1111/j.1750-2659.2007.00027.x10.1111/j.1750-2659.2007.00027.xSearch in Google Scholar
[132] Fedson D.S., Confronting an influenza pandemic with inexpensive generic agents: can it be done?, Lancet Infect. Dis., 2008, 8, 571–576 http://dx.doi.org/10.1016/S1473-3099(08)70070-710.1016/S1473-3099(08)70070-7Search in Google Scholar
[133] Dwek R.A., Butters T.D., Platt F.M., Zitzmann N., Targeting glycosylation as a therapeutic approach, Nat. Rev. Drug Discov., 2002, 1, 65–75 http://dx.doi.org/10.1038/nrd70810.1038/nrd708Search in Google Scholar PubMed
[134] Chang J., Schul W., Butters T.D., Yip A., Liu B., Goh A., et al., Combination of alpha-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo, Antiviral Res., 2011, 89, 26–34 http://dx.doi.org/10.1016/j.antiviral.2010.11.00210.1016/j.antiviral.2010.11.002Search in Google Scholar PubMed PubMed Central
[135] Chang J., Wang L., Ma D., Qu X., Guo H., Xu X., et al., Novel imino sugar derivatives demonstrate potent antiviral activity against flaviviruses, Antimicrob. Agents Chemother., 2009, 53, 1501–1508 http://dx.doi.org/10.1128/AAC.01457-0810.1128/AAC.01457-08Search in Google Scholar
[136] Vancova M., Nebesarova J., Grubhoffer L., Lectin-binding characteristics of a Lyme borreliosis spirochete Borrelia burgdorferi sensu stricto, Folia Microbiol., (Praha), 2005, 50, 229–238 http://dx.doi.org/10.1007/BF0293157110.1007/BF02931571Search in Google Scholar
[137] Logan S.M., Hui J.P., Vinogradov E., Aubry A.J., Melanson J.E., Kelly J.F., et al., Identification of novel carbohydrate modifications on Campylobacter jejuni 11168 flagellin using metabolomics-based approaches, FEBS J., 2009, 276, 1014–1023 http://dx.doi.org/10.1111/j.1742-4658.2008.06840.x10.1111/j.1742-4658.2008.06840.xSearch in Google Scholar
[138] Appelmelk B.J., den Dunnen J., Driessen N.N., Ummels R., Pak M., Nigou J., et al., The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium-host interaction, Cell Microbiol., 2008, 10, 930–944 http://dx.doi.org/10.1111/j.1462-5822.2007.01097.x10.1111/j.1462-5822.2007.01097.xSearch in Google Scholar
[139] Twine S.M., Paul C.J., Vinogradov E., McNally D.J., Brisson J.R., Mullen J.A., et al., Flagellar glycosylation in Clostridium botulinum, FEBS J., 2008, 275, 4428–4444 http://dx.doi.org/10.1111/j.1742-4658.2008.06589.x10.1111/j.1742-4658.2008.06589.xSearch in Google Scholar
[140] Romanova J., Katinger D., Ferko B., Voglauer R., Mochalova L., Bovin N., et al., Distinct host range of influenza H3N2 virus isolates in Vero and MDCK cells is determined by cell specific glycosylation pattern, Virology, 2003, 307, 90–97 http://dx.doi.org/10.1016/S0042-6822(02)00064-810.1016/S0042-6822(02)00064-8Search in Google Scholar
[141] Wright K.E., Spiro R.C., Burns J.W., Buchmeier M.J., Post-translational processing of the glycoproteins of lymphocytic choriomeningitis virus, Virology, 1990, 177, 175–183 http://dx.doi.org/10.1016/0042-6822(90)90471-310.1016/0042-6822(90)90471-3Search in Google Scholar
[142] Branco L.M., Garry R.F., Characterization of the Lassa virus GP1 ectodomain shedding: implications for improved diagnostic platforms, Virol. J., 2009, 6, 147 http://dx.doi.org/10.1186/1743-422X-6-14710.1186/1743-422X-6-147Search in Google Scholar PubMed PubMed Central
[143] Martinez I., Melero J.A., Binding of human respiratory syncytial virus to cells: implication of sulfated cell surface proteoglycans, J. Gen. Virol., 2000, 81, 2715–2722 10.1099/0022-1317-81-11-2715Search in Google Scholar PubMed
[144] Feinberg H., Castelli R., Drickamer K., Seeberger P.H., Weis W.I., Multiple modes of binding enhance the affinity of DC-SIGN for high mannose N-linked glycans found on viral glycoproteins, J. Biol. Chem., 2007, 282, 4202–4209 http://dx.doi.org/10.1074/jbc.M60968920010.1074/jbc.M609689200Search in Google Scholar PubMed PubMed Central
© 2011 Versita Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.